Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

Author: Hartmann M.   Fedders M.   Schneider A.   Kath R.   Camara O.   Oelschläger H.  

Publisher: Springer Publishing Company

ISSN: 0171-5216

Source: Journal of Cancer Research and Clinical Oncology, Vol.133, Iss.9, 2007-09, pp. : 619-625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content